NIH

October 6, 2017October 9, 2017

Evidence of Lymph Vessels in Human Brain May Offer New Insights into MS, Other Disorders

News

Groundbreaking evidence of the existence of lymphatic vessels in the human brain could answer the question of how the brain gets rid of waste products, and ... Read more

August 23, 2017August 24, 2017

Nortis Awarded $688K Grant from NIH to Develop ‘Living’ Model of Blood-Brain Barrier for Research

News

Nortis, a Seattle-based biotech company, has received a $688,000 grant by the National Institutes of Health to create a living, 3-D model of the human blood-brain ... Read more

June 15, 2017June 16, 2017

IQuity Given $1M NIH Grant to Advance Research into RNA-based Diagnostic Tests for MS

News

The National Institutes of Health (NIH) has awarded a $1 million grant to IQuity, a Nashville-based company looking into novel RNA targets that ultimately benefit patients ... Read more

January 23, 2017January 23, 2017

MS Researcher at Cleveland Clinic Awarded $7M to Pursue Ways of Stopping Myelin Damage

News

Two Cleveland Clinic researchers were awarded multi-year grants by the National Institutes of Health (NIH), under its Outstanding Investigator Award, to find new treatments for multiple sclerosis (MS) and other ... Read more

November 29, 2016November 29, 2016

NIH Grant to Support Research into Role of Copper in Demyelination

News

The National Institutes of Health (NIH) awarded a $45,000 grant to a team of investigators, led by Tia Walker, PhD, at Indiana University Northwest, to support a research project ... Read more

September 26, 2016September 26, 2016

StemGenex CSO Tells FDA at Hearing to Regulate Adult Stem Cell Therapies as ‘Blood Tissue Product’

News

In a presentation at a U.S. Food and Drug Administration (FDA) public hearing earlier this month, the chief scientific officer of StemGenex Medical Group, Steven A. Brody, ... Read more

September 22, 2016September 22, 2016

Information on Clinical Trials to Be More Complete and Accessible Under New HHS Rules

News

The U.S. Department of Health and Human Services (HHS) recently announced policy changes designed to make information about clinical trials of investigational drugs, biologics and products more ... Read more

August 31, 2016August 31, 2016

Welcome or Not, FDA Focuses on Stem Cell Treatments

Columns, What's Important Now -- An MS Column by Ian Franks

News that the U.S. Food and Drug Administration (FDA) is to hold a public hearing next month to consider greater oversight of stem cell clinics operating ... Read more

January 4, 2016

Last Week’s Top-3 Most Read Posts On Multiple Sclerosis

Read the Articles Here: Rare Brain Infection Death Spurs FDA To Update Warning Label for MS Drug MS Patients Are Adequately, But Not Optimally, Treated for ... Read more

December 30, 2015December 30, 2015

NIH Grant to Advance Multiple Sclerosis Therapy Targeting Remyelination

News

Novoron Bioscience, Inc., a biotech company focused on developing therapies for disorders of the central nervous system, recently announced that it has received a $680,000 National ... Read more

September 11, 2014October 21, 2015

Multiple Sclerosis Trial for Lisinopril Granted $1.4 Million in New Funding From NCATS

Multiple Sclerosis News, News

Transparency Life Sciences, LLC (TLS), the first clinical-stage drug development company based on open innovation in the world, recently received a $1.4 million Small Business Innovation Research (SBIR) grant intended for ... Read more

Pin It on Pinterest